Skip to main content
Start of content

INST Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication
Meeting No. 4
Thursday, February 26, 2004

The Standing Committee on Industry, Science and Technology met in a televised session at 9:31 a.m. this day, in Room 253-D Centre Block, the Chair, Brent St. Denis, presiding.


Members of the Committee present: Paul Crête, Hon. Joe Fontana, Cheryl Gallant, Hon. Gurbax Malhi, Grant McNally, James Rajotte, Carol Skelton, Brent St. Denis and Hon. Lyle Vanclief.


Acting Members present: Alexa McDonough for Brian Masse, Réal Ménard for Jocelyne Girard-Bujold and Paddy Torsney for Marlene Jennings.


In attendance: Library of Parliament: Lalita Acharya, Analyst; Dan Shaw, Analyst; Kristen Douglas, Analyst.


Witnesses: Canada's Research-Based Pharmaceutical Companies (Rx&D): Jean-François Leprince, President, Aventis Pharma; Terry McCool, Vice-President, Corporate Affairs, Eli Lilly Canada Inc. Canadian Generic Pharmaceutical Association: Jim Keon, President; David Windross, Vice-President, Government and Professional Affairs, Novopharm Limited. Doctors Without Borders: Rachel Kiddell-Monroe, Coordinator (Canada) Access to Essential Medicines Campaign; Virginia Gularte, Medical Doctor, MSF Guatemala. Oxfam Canada: Mark Fried, Communications and Advocacy Coordinator. Canadian HIV/AIDS Legal Network: Richard Elliott, Director, Policy and Legal Research. Interagency Coalition on AIDS and Development: Michael O'Connor, Executive Director. CARE Canada: Michelle Munro, Policy and Programs Advisor, HIV/AIDS and Health.

Pursuant to the Order of Reference of Thursday, February 12, 2004, the Committee resumed consideration of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act.

The witnesses made statements and answered questions.


At 11:04 a.m., the sitting was suspended.

At 11:10 a.m., the sitting resumed.


The witnesses made statements and answered questions.


At 12:33 p.m., the Committee adjourned to the call of the Chair.


Louise M. Thibault
Clerk of the Committee

2004/03/01 2:32 p.m.